. 2020 May 28;4(5):848–859. doi: 10.1002/rth2.12342

Table 5.

Sensitivity, specificity, and positive and negative predictive values of the Thrombogyn and extended Thrombogyn score in the biomarker cohort (n = 290)

	Sensitivity (%) (95% CI)	Specificity (%) (95% CI)	Positive predictive value (%) (95% CI)	Negative predictive value (%) (95% CI)	Area under curve (95% CI)
Thrombogyn
High risk (score ≥ 2))	63.6 (40.6‐82.8)	76.0 (70.4‐81.0)	17.9 (13.0‐24.2)	96.2 (96.5‐97.9)	0.759 (0.658‐0.865)
Intermediate/high risk (score ≥ 1)	100 (84.6‐100.0)	23.5 (18.5‐29.0)	9.7 (9.1‐10.3)	100 …
Extended Thrombogyn
High risk (score ≥ 4))	36.3 (18.0‐59.2)	95.7 (92.5‐97.8)	42.1 (21.1‐66.0)	94.8 (91.2‐97.0)	0.784 (0.681‐0.886)
Intermediate/high risk (score ≥ 2)	81.8 (59.7‐94.8)	54.6 (48.3‐60.5)	12.8 (10.4‐15.7)	97.3 (93.7‐98.9)

Sensitivity (%)

(95% CI)

Specificity (%)

(95% CI)

Positive predictive value (%)

(95% CI)

Negative predictive value (%)

(95% CI)

Area under curve

(95% CI)

Thrombogyn

High risk

(score ≥ 2))

63.6

(40.6‐82.8)

76.0

(70.4‐81.0)

17.9

(13.0‐24.2)

96.2

(96.5‐97.9)

0.759

(0.658‐0.865)

Intermediate/high risk

(score ≥ 1)

100

(84.6‐100.0)

23.5

(18.5‐29.0)

9.7

(9.1‐10.3)

100

…

Extended Thrombogyn

High risk

(score ≥ 4))

36.3

(18.0‐59.2)

95.7

(92.5‐97.8)

42.1

(21.1‐66.0)

94.8

(91.2‐97.0)

0.784

(0.681‐0.886)

Intermediate/high risk

(score ≥ 2)

81.8

(59.7‐94.8)

54.6

(48.3‐60.5)

12.8

(10.4‐15.7)

97.3

(93.7‐98.9)